Lilly Completes Acquisition of Applied Molecular Evolution
AME stockholders will receive $18 for each AME share in the form of cash, Lilly common stock or a combination of cash and Lilly common stock, based on elections made by AME stockholders and subject to the proration and adjustment mechanisms of the merger agreement. Today's closing price of Lilly common stock of $73.58 per share results in an exchange ratio of 0.2446 of a Lilly share per AME share for those AME stockholders receiving the stock consideration.
Most read news
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.